Monographie - Flucloxacillin sodium

Flucloxacillin sodium

Kémiai szerkezet

Kereskedelmi név

A kereskedelmi név meghatározó jelentőségű: a készítmények összetétele országonként, előállítóként eltérő lehet

Astaph	Marokkó
Betabiotic	Olaszország
DBL flucloxacillin sodium	Ausztrália
Flix	Törökország
Floxam	Marokkó
Floxapen	Amerikai Egyesült Államok, Ausztria, Belgium, Hollandia, Lengyelország, Marokkó, Olaszország, Portugália, Svájc, Szaúd-Arábiában
Flucloxacillin	Nagy-Britannia, Németország, Olaszország
Flucloxacilline	Hollandia
Flucloxin	új-Zéland
Ladropen	Amerikai Egyesült Államok
Stafoxil	Hollandia
Staphylex	Németország

Irodalom : Flucloxacillin sodium

	Type	publikáció
186	Napló	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
889	Napló	Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. Ofloxacin intravenous. Compatibility with other antibacterial agents. Pharm Weekbl [Sci] 1991 ; 13: 207-209.
939	Napló	Gilbar PJ, Groves CF. Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection. Aust J Hosp Pharm 1994 ; 24: 167-170.
1232	Napló	Beatson C, Taylor A. A physical compatibility study of furosemide & flucloxacillin injections. Br J Pharm Pract 1987 ; 9: 223-226, 236.
1300	Napló	Ahmed ST, Parkinson R. The stability of drugs in pre-filled syringes: flucloxacillin, ampicillin, cefuroxime, cefotaxime and ceftazidime. Hosp Pharm Pract 1992 ; 2: 285-289.
1349	Napló	Sanburg AL, LyndonRC, Sunderland B. Effects of freezing, long term storage and microwave thawing on the stability of three antibiotics reconstituted in minibags. Aust J Hosp Pharm 1987 ; 17: 31-34.
1357	Napló	Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. Quinolones and penicillins incompatibility. Ann Pharmacotherapy 1989 ; 23: 91-92.
1494	Napló	McLaughlin JP, Simpson C. When is flucloxacillin stable ? Hosp Pharm Pract 1993 ; 3: 553-556.
1845	Napló	Müller HJ, Haker I. The stability of amoxicillin, ampicillin, benzylpenicillin, flucloxacillin, mezlocillin and piperacillin in isotonic saline solutions when stored in an innovative infusion container (Freeflex container). EJHP 2003 ; 6: 106-111.
2231	Napló	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3091	Napló	Thalhammer F, Maier-Salamon A, Jäger W. Prüfung von Stabilität und Kompatibilität von Flucloxacillin (Floxapen®) und Ceftazidim (Fortum®) in zwei Infusionslösungen:Relevanz für die klinische Praxis. Wien Med Wochenschr 2005 ; 155, 13-14: 337-343.
3189	Napló	Tho T-P, Ching MS, Elis AG, Williams L, Garrett MK. Stability of intravenous flucloxacillin solutions used for hospital-in-the-home. J Pharm Pract and Res 2010 ; 40, 2: 101-105.
3385	Napló	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3522	Laboratórium	Flucloxacillin - Summary of Product Characteristics. Actavis 2013
3529	Laboratórium	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3585	Laboratórium	Benzylpenicillin sodium - Summary of Product Characteristics Genus Pharmaceuticals 2008
3643	Laboratórium	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratórium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
4218	Napló	Allwood M.C,Stonkute D, Wallace A, Wilkinson A-S, Hills T, Jamieson C, Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements. EJHP 2020 ; 27, 2: 90-94.
4538	Napló	Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K. Compatibility of pentoxifylline and parenteral medications. Archives of Disease in Childhood 2020 ; 105: 395-397.
4590	Napló	Smith E.K, McWhinney MPhil B.C. Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service. J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4837	Napló	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.